Compare SFIX & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFIX | BBNX |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 583.4M | 613.7M |
| IPO Year | 2017 | 2025 |
| Metric | SFIX | BBNX |
|---|---|---|
| Price | $3.28 | $13.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | $6.00 | ★ $27.58 |
| AVG Volume (30 Days) | ★ 2.0M | 1.1M |
| Earning Date | 03-10-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,290,480,000.00 | $88,570,000.00 |
| Revenue This Year | $7.80 | $53.88 |
| Revenue Next Year | $3.07 | $34.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $2.60 | $8.89 |
| 52 Week High | $5.94 | $32.71 |
| Indicator | SFIX | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 22.41 | 32.07 |
| Support Level | $4.85 | $13.25 |
| Resistance Level | $4.19 | $15.53 |
| Average True Range (ATR) | 0.32 | 1.01 |
| MACD | -0.16 | 0.44 |
| Stochastic Oscillator | 0.62 | 28.01 |
Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.